Talk:Dalbavancin

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Dalbavancin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

clinical trial details and results

Article could use references to clinical trial details and results. - Rod57 (talk) 12:28, 10 May 2011 (UTC)[reply]

It also neglects to mention that most MRSA strains are susceptible to common antibiotics such as tmp-smx, doxycycline and clindamycin. — Preceding unsigned comment added by 69.4.130.98 (talk) 18:27, 2 September 2015 (UTC)[reply]

Trial

Non-inferior to vancomycin +/- linezolid. doi:10.1056/NEJMoa1310480 JFW | T@lk 14:16, 9 June 2014 (UTC)[reply]

Dalbavancin is a mixture of 5 different molecules

The chemical and physical data and the chemical structure suggest that Dalbavancin is one defined molecule. However, as per the EMA public assessment report it is a mixture of five molecules: Dalbavancin A0 and A1, Dalbavancin B0, B1 and B2. They differ from one another primarily in the length and/or branching of their respective fatty acid side chains. See page 10 ^[1]

--Kereul (talk) 17:39, 14 January 2017 (UTC)[reply]

References

^ http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002840/WC500183871.pdf

What do I use for it to tack rash away

Need to take rash away 2600:1012:B10A:68BE:411:73F:FFCA:2AC6 (talk) 05:29, 15 April 2024 (UTC)[reply]

It's been three day and it getting worse 2600:1012:B10A:68BE:411:73F:FFCA:2AC6 (talk) 05:30, 15 April 2024 (UTC)[reply]

[1] ttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002840/WC500183871.pdf

[1]

Talk:Dalbavancin

clinical trial details and results

Trial

Dalbavancin is a mixture of 5 different molecules

What do I use for it to tack rash away

Navigation menu

Search